Patents by Inventor Richard Dalby

Richard Dalby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ultrasonic flow measurement system including a signal generator exciting the transducers and a phase differentiator
    Patent number: 11243558
    Abstract: An ultrasonic flow measurement system may include a signal generator configured to generate a first excitation signal for a first ultrasonic transducer and a second excitation signal for a second, different ultrasonic transducer. The system may further include a phase differentiator configured to generate a differential phase angle signal indicative of a difference in phase angle between first and second receive signals received from the first and second transducers which is indicative of flow rate.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: February 8, 2022
    Assignee: Renesas Electronics Corporation
    Inventors: Axel Kleinitz, Richard Dalby
  • Ultrasonic Flow Measurement
    Publication number: 20200209030
    Abstract: An ultrasonic flow measurement system may include a signal generator configured to generate a first excitation signal for a first ultrasonic transducer and a second excitation signal for a second, different ultrasonic transducer. The system may further include a phase differentiator configured to generate a differential phase angle signal indicative of a difference in phase angle between first and second receive signals received from the first and second transducers which is indicative of flow rate.
    Type: Application
    Filed: June 12, 2017
    Publication date: July 2, 2020
    Inventors: Axel Kleinitz, Richard Dalby
  • Phospholipid-based inhalation system
    Patent number: 8591954
    Abstract: The present invention includes a method for delivering medications deeper into the lungs and to the medications' pulmonary targets, which include bronchioles and alveoli. A first particularly preferred embodiment of the invention describes the use of two steps for delivery of a medication. In a first step, an aerosolized therapeutic composition or medication is administered into a patient's respiratory tract, wherein the patient may be any animal or human subject. Following the first step, an aerosolized surfactant is administered into the patient's respiratory tract that facilitates delivery of the aerosolized medication of the first step to the medication's pulmonary target. Another embodiment of the present invention contemplates an apparatus for the delivery of an aerosolized surfactant used that facilitates delivery of previously inhaled aerosolized medication.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: November 26, 2013
    Assignee: Next Breath, LLC
    Inventors: Shailaja Somaraju, Julie Suman, Sudipta Ganguly, Richard Dalby
  • Methods and compositions for treatment of intraepithelial neoplasia
    Patent number: 8440648
    Abstract: The present invention provides for compositions, kits and methods for treatment of intraepithelial neoplasia, where the compositions include catecholic butanes, which include NDGA derivatives.
    Type: Grant
    Filed: July 19, 2005
    Date of Patent: May 14, 2013
    Assignees: Erimos Pharmaceuticals LLC, University of Maryland, Baltimore, Johns Hopkins University
    Inventors: Neil Frazer, Jonathan Heller, Rocio Lopez, Melissa Rhodes, Ru Chih C. Huang, Richard Dalby, Niharika Khanna
  • Phospholipid-based inhalation system
    Patent number: 8206687
    Abstract: The present invention includes a method for delivering medications deeper into the lungs and to the medications' pulmonary targets, which include bronchioles and alveoli. A first particularly preferred embodiment of the invention describes the use of two steps for delivery of a medication. In a first step, an aerosolized therapeutic composition or medication is administered into a patient's respiratory tract, wherein the patient may be any animal or human subject. Following the first step, an aerosolized surfactant is administered into the patient's respiratory tract that facilitates delivery of the aerosolized medication of the first step to the medication's pulmonary target. Another embodiment of the present invention contemplates an apparatus for the delivery of an aerosolized surfactant used that facilitates delivery of previously inhaled aerosolized medication.
    Type: Grant
    Filed: October 26, 2007
    Date of Patent: June 26, 2012
    Assignee: Next Breath, LLC
    Inventors: Shailaja Somaraju, Julie Suman, Richard Dalby, Sudipta Ganguly
  • Methods and Compositions for Treatment of Intraepithelial Neoplasia
    Publication number: 20080004346
    Abstract: The present invention provides for compositions, kits and methods for treatment of intraepithelial neoplasia, where the compositions include catecholic butanes, which include NDGA derivatives.
    Type: Application
    Filed: July 19, 2005
    Publication date: January 3, 2008
    Applicants: ERIMOS PHARMACEUTICALS LLC, JOHNS HOPKINS UNIVERSITY, UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Neil Frazer, Jonathan Heller, Rocio Lopez, Melissa Rhodes, Ru Chih Huang, Richard Dalby, Niharika Khanna